April 2008
Established a multi-year collaboration with Bristol-Myers Squibb Company to obtain crystal structures of G-protein coupled receptors to enable discovery of novel medicines for unmet medical needs.
December 2007
Signed a collaborative agreement with Lundbeck A/S of Denmark whereby ConfometRx, Inc will obtain crystal structures of two G-protein coupled receptors for Lundbeck A/S. The agreement is based on upfront and milestone payments.
November 2006
Work on the second target from Medarex was initiated.
March 2006
Awarded Phase I SBIR Grant to develop a flourescent screening assay based on ConfoTeG technology.
August 2005
ConfometRx has entered into a partnership with Medarex, Inc. to generate novel immunogens. We are providing Medarex
with high-quality protein preparations produced using our proprietary technology for membrane-associated protein expression and purification.